Saturday, February 28, 2015 12:28:39 PM
A/S 250,000,000 * (currently 10 Billion as issued by prior ceo).
Market Cap as of 2/20/2015: $73,025.12 (pps .0007)
(10K will be filed in March per ceo)
*New ceo Brent Suen recently represented a tentative reduction in the authorized to around 250 million: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=111032651
Remaining convertible STOA debt as of 2/19/2015 was $4,000. Some OR ALL of this cb debt was converted on 2/20 & 2/27 (since this last update): http://investorshub.advfn.com/boards/read_msg.aspx?message_id=110992997
Potential news pending. 2/13/2015 update from ceo: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=110835032
12/16/2014: PR (acquisition discussions): http://www.1888pressrelease.com/seratosa-enters-into-acquisition-talks-with-us-based-adventu-pr-550701.html
Most recent STOA filings (1/26/15-2/17/15). Many amended 10K's & Q's: http://www.otcmarkets.com/stock/STOA/filings
Recent LGIQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 02:43:28 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 09:08:29 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 11/13/2023 09:30:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 08:11:35 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/25/2023 09:04:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2023 09:03:09 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/10/2023 10:48:27 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 04:28:19 PM
- Form PREM14A - Preliminary proxy statements relating to merger or acquisition • Edgar (US Regulatory) • 09/29/2023 09:20:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 08:32:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 05:05:22 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:57:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2023 01:51:06 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM